https://www.avient.com/resources/safety-data-sheets?page=6028
X 33344-01-3
X 33344-01-4
Geon(TM) DM713 WHITE Q728-3-5 (7410-001)
https://www.avient.com/sites/default/files/2024-05/AVNT Q1 2024 Investor Presentation_website w Non-GAAP.pdf
Expand EBITDA margins to
20%
3.
Continue fostering our Great
Place to Work® culture
Strategic ObjectivesStrategic Objectives
Long Term
Growth
Rates
Growth DriversGrowth Drivers
$340
$455
$790
$1,135
2016 2018 2020 2023
$51
$84
$212
$645
2016 2018 2020 2023
$108 $113
$231 $230
2016 2018 2020 2023
$265
$358
$726 $725
2016 2018 2020 2023
8-12% 8-10% 8-10% 5%
Sustainable Solutions Composites Healthcare Asia/Emerging Regions
Profitable GrowthProfitable Growth Great Place to WorkGreat Place to Work
5.4%
10.9%
16.0%
2006 2014 2023
EBITDA Margins
$0.14
$1.93
$2.36
2006 2014 2023
Adjusted EPS
TO P- T IE R S US TA I NA B I L I TY PE R F OR MA N C E
A N D R EC O G NI T I ON
Industry Sustainability Standards
ESG Ratings Performance
1
2
4
87th
94th
percentile
5
Avient CDP Score:
A-
M AY 7 , 2 0 2 4
W E B C A S T
P R E S E N TA T I O N
7
REGIONAL DEMAND TREND S-TOTA L COMPA NY
Q 1 S A L E S V S P Y ( E X C L U D I N G F X )
7
US & Canada
Latin America
EMEA
Asia
+2%
-6%
Flat
+2%
Avient ex.
FX -1.5%
FX -0.5%
Total Avient -2.0%
Q 1 2 0 2 4 R E S U L T S
Q1 2024 PERFORMANCE VS.
https://www.avient.com/resources/safety-data-sheets?page=3957
PP Q728-1-3 GREY 2 1S
MCK LT AMBER PET 4
TPE 2S SPOUT CAP Q728-3-2 GREY 4
https://www.avient.com/resources/safety-data-sheets?page=5285
X ET 280490#SR-27609-1-WHITE
X ET 280490#SR-27609-3 Teal
X ET 280490#SR-27609-4 Blue
https://www.avient.com/sites/default/files/2022-02/AVNT Q4 2021 Earnings Presentation_0.pdf
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
26
Capex / Revenue
2022E (%)
AV I E N T I S A SS E T L I G H T
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
2
3
2
2
3
3
4
3
3
5
5
5
7
7 7
A
vi
e
n
t
A
vi
e
n
t
(E
xc
l.
D
is
t.
)
K
W
R
P
P
G
F
U
L
R
P
M
A
V
Y
F
M
C
H
U
N
H
X
L
S
C
L
E
C
L
E
M
N
C
E
A
S
H
Source: Peer data per Bloomberg market data as of February 15, 2022.
O U R VA LUATI O N V E R S U S P E E R S
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
5.4
8.5
10.1 10.0
15.7
15.0
14.2
12.7
10.2
25.0
19.7
17.7
13.2
12.3
10.0 9.9
8.9 8.5 8.3
6.6
A
vi
e
n
t
(2
0
1
1
)
A
vi
e
n
t
(2
0
1
6
)
A
vi
e
n
t
(2
0
2
1
)
A
vi
e
n
t
(T
o
d
a
y)
R
P
M
K
W
R
P
P
G
A
V
Y
F
U
L
A
L
B
E
C
L
H
X
L
A
S
H
F
M
C
B
N
R
E
M
N
U
N
V
R
C
E
S
C
L
H
U
N
Historic Multiple
S U M M A RY: W H Y I N V E S T I N AV I E N T ?
https://www.avient.com/idea/medical-hose-manufacturer-boosts-productivity-specialized-material
The elastomeric material, used to overmold a cuff on the end of the hose, demonstrated inconsistent quality and subpar flow properties.
Cost savings: The hose manufacturer saves $33,000 per year by using Versalloy TPV instead of its previous material.
Higher productivity: The improved flow properties of the Versalloy solution enabled the hose manufacturer to increase throughput by two seconds, which in turn reduced total system costs.
https://www.avient.com/resources/safety-data-sheets?page=4165
X S1054A F-3 Natural
X S1054A F-4 Natural
72-3-5CPFXAB EPIC PANTONE(R) 72-3-5C SIM
https://www.avient.com/resources/safety-data-sheets?page=3215
AMETHYST #3
CAMEL 4
X ST335-001-04 Natural
https://www.avient.com/sites/default/files/2023-08/AVNT August IR Presentation w NonGAAP Recs%5B40%5D.pdf
Expand EBITDA margins to 20%
3.
Deliver annual EBITDA and EPS
growth of 10% and 15%
4.
Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years.
28
EV / 2023E EBITDA
Historic Multiple
6.5
8.3
9.5
13.8
12.7 12.6
11.3
8.7
18.6
16.5
10.1 10.0 9.7 9.5 9.4
8.7
A
vi
e
n
t
(2
0
1
1
)
A
vi
e
n
t
(2
0
1
8
)
A
vi
e
n
t
(2
0
2
3
)
R
P
M
P
P
G
A
V
Y
K
W
R
F
U
L
E
C
L
H
X
L
F
M
C
A
S
H
S
C
L
H
U
N
C
E
E
M
N
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
SEGMENT DATA
U.S. & Canada
40%
EMEA
37%
Asia
18%
Latin America
5%
2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
Consumer
20%
Packaging
24%
Industrial
15%
Building and
Construction
10%
Telecommunications
4%
Energy
4%
Defense
6%
END MARKET REVENUE
$2,355M $402M
$1,300M $272M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$592M$3,653M
(1)
Transportation
9%
Healthcare
8%
30
(1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs
2 0 2 2 R E V E N U E | $ 2 . 4 B I L L I O N
US & Canada
34%
EMEA
38%
Asia
20%
Latin America
8%
END MARKET REGION
31
Packaging
34%
Consumer
21%
Healthcare
8%
Industrial
15%
Transportation
8%
Building &
Construction
11%
Telecommunications
1% Energy
2%
COLOR , AD DI TI VES & INKS
2 0 2 2 P R O F O R M A R E V E N U E | $ 1 . 3 B I L L I O N
US & Canada
52%
EMEA
35%
Asia
13%
32
Packaging
5%
Consumer
19%
Healthcare
8%Industrial
16%
Transportation
10%
Telecommunications
10%
Energy
9% Defense
15%
Building &
Construction
8%
END MARKET REGION
SPEC IA LTY ENGI NEER ED MATERI ALS
Packaging
32%
Consumer
27%
Healthcare
8%
Industrial
14%
Building &
Construction
5%
Telecommunications
3%
Energy
1% Defense
1%
Asia
(18% of sales)
Transportation
9%
2 0 2 2 P R O F O R M A AV I E N T R E G I O N A L S A L E S
Packaging
27%
Consumer
14%
Healthcare
5%
Industrial
17%
Building &
Construction
10%
Energy
5%
Defense
8%
EMEA
(37% of sales)Transportation
11%
Packaging
13%
Consumer
24%
Healthcare
12%
Industrial
15%
Building &
Construction
13%
Energy
5%
Defense
5%
US &
Canada
(40% of sales)
Transportation
7%
Packaging
56%
Consumer
23%
Healthcare
4%
Industrial
7%
Building &
Construction
4%
Telecommunications
1%
LATAM
(5% of sales)
Transportation
5%
Telecommunications
3%
Telecommunications
6%
33
B Y E N D M A R K E T
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/resources/safety-data-sheets?page=4262
X MF-13535-001-1 Natural
X MF-13535-001-3 Natural
X MF-13535-001-4 Natural